Agilent Technologies
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Agilent Technologies (A) Business News
Track Agilent Technologies in real time with a live news feed covering Agilent Technologies stock news, official press releases, company announcements, and an archive of historical Agilent Technologies news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
Agilent Q1 Earnings Miss Estimates, Revenues Up Y/Y, Shares Fall
Agilent Q1 Earnings Miss Estimates, Revenues Up Y/Y, Shares Fall
Agilent Technologies, Inc. (A) Q1 2026 Earnings Call Transcript
Agilent (A) Reports Q1 Earnings: What Key Metrics Have to Say
Agilent Technologies (A) Lags Q1 Earnings and Revenue Estimates
Agilent reports in-line first quarter, says results hurt by US snowstorm
Agilent Reports First-Quarter Fiscal Year 2026 Financial Results
Agilent to Participate in TD Cowen's 46th Annual Health Care Conference
CenterBook Partners LP Buys Shares of 10,386 Agilent Technologies, Inc. $A
Stay Ahead of the Game With Agilent (A) Q1 Earnings: Wall Street's Insights on Key Metrics
Assetmark Inc. Boosts Position in Agilent Technologies, Inc. $A
Agilent Q1 Earnings Miss Estimates, Revenues Up Y/Y, Shares Fall
1:55 PM | Thursday | Feb 26, 2026
A posts Q1 revenue growth and beats sales estimates, but margin pressure and earnings miss send shares lower in pre-market trade.
Read full article
Agilent Q1 Earnings Miss Estimates, Revenues Up Y/Y, Shares Fall
Zacks Investment ResearchA posts Q1 revenue growth and beats sales estimates, but margin pressure and earnings miss send shares lower in pre-market trade.
Read full article
Agilent Q1 Earnings Miss Estimates, Revenues Up Y/Y, Shares Fall
Zacks Investment ResearchA posts Q1 revenue growth and beats sales estimates, but margin pressure and earnings miss send shares lower in pre-market trade.
Read full article
Agilent Technologies, Inc. (A) Q1 2026 Earnings Call Transcript
Seeking AlphaAgilent Technologies, Inc. (A) Q1 2026 Earnings Call Transcript
Read full article
Agilent (A) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks Investment ResearchWhile the top- and bottom-line numbers for Agilent (A) give a sense of how the business performed in the quarter ended January 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read full article
Agilent Technologies (A) Lags Q1 Earnings and Revenue Estimates
Zacks Investment ResearchAgilent Technologies (A) came out with quarterly earnings of $1.36 per share, missing the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $1.31 per share a year ago.
Agilent reports in-line first quarter, says results hurt by US snowstorm
ReutersLife sciences firm Agilent Technologies on Wednesday reported first-quarter results that were largely in line with Wall Street estimates on stable demand for its medical tools and equipment used in lab research and diagnostic services.
Read full article
Agilent Reports First-Quarter Fiscal Year 2026 Financial Results
Business WireSANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #CustomerFirst--Agilent Technologies, Inc. (NYSE: A) today reported revenue of $1.80 billion for the first quarter ended Jan. 31, 2026, representing growth of 7.
0% reported and up 4.4% core(1) compared with the first quarter of 2025. First-quarter GAAP net income was $305 million, or $1.07 per share. This compares with $318 million, or $1.
11 per share, in the first quarter of 2025. Non-GAAP(2) net income was $386 million, or $1.36 per share, during the quarter, compared wi.
Agilent to Participate in TD Cowen's 46th Annual Health Care Conference
Business WireSANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today announced that Chief Financial Officer Adam Elinoff and Head of Investor Relations Tejas Savant will participate in a fireside chat at TD Cowen's 46th Annual Health Care Conference. The event is scheduled for 11:10 to 11:40 a.m.
EST on Tuesday, March 3, 2026, in Boston, Massachusetts. A live audio webcast and replay of the presentation will be available through Agilent's Investor Relations website. About Agilent Tec.
CenterBook Partners LP Buys Shares of 10,386 Agilent Technologies, Inc. $A
Defense WorldCenterBook Partners LP acquired a new position in shares of Agilent Technologies, Inc. (NYSE: A) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 10,386 shares of the medical research company's stock, valued at approximately $1,333,000. Other institutional investors and hedge funds
Read full article
Stay Ahead of the Game With Agilent (A) Q1 Earnings: Wall Street's Insights on Key Metrics
Zacks Investment ResearchGet a deeper insight into the potential performance of Agilent (A) for the quarter ended January 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Read full article
Assetmark Inc. Boosts Position in Agilent Technologies, Inc. $A
Defense WorldAssetmark Inc. increased its position in Agilent Technologies, Inc. (NYSE: A) by 6.2% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 221,291 shares of the medical research company's stock after purchasing an additional 12,997 shares during the quarter.